Label: SEEQUIN 2- hydroquinone liquid

  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated November 6, 2013

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

  • Active Ingredient

    Hydroquinone (2%)

  • Indication

    Skin Lightening

  • Indication

    To gradually lighten hyperpigmentation of the skin such as age spots, liver spots, freckles, or other areas of unwanted melanin hyperpigmentation that may occur in pregnancy or from the use of oral contraceptives.

  • Precautions

    For external use only. A mild transient stinging may occur for people with sensitive skin. Do not use on broken or irritated skin. Discontinue use if irritation or rash occurs. Avoid contact with eyes and mucous membranes. In case of contact, rinse thoroughly with water. Do not use on children under 12 years of age. Keep out of reach of children. Avoid use around the eyes and lips.

  • Precautions

    keep away from children.

  • Directions

    Remove and discard solid white cap from bottle and replace with dropper cap. Test for skin sensitivity before using by applying 1 or 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum * to an area of unbroken skin about 25 mm in diameter. If excessive irritation, rash or other reaction develops within 24 hours, discontinue use. To apply, place 1 to 2 drops of SEEQUIN™ 2 IDS™ Liquid Gel S-erum* in the palm of your hand and use fingertips to apply a thin layer to the affected areas. Use both morning and night or as directed by a physician. Depigmentation is a gradual process and results should be expected within 12 weeks of daily use. Discontinue use if no results are apparent after 8 weeks. To maintain results, use several times per week or as directed by a physician. Limit sun exposure during treatment by using protective clothing or a sunscreen protective agent to avoid re-darkening of the skin. Close dropper cap securely after each use. Store at room temperature (15-25°C / 59-77°F).

  • Non-Medicinal Ingredients

    CITRUS GRANDIS (GRAPEFRUIT) EXTRACT, ETHOXYDIGLYCOL, FRAGRANCE/ PARFUM, L-ASCORBIC ACID USP, PROPYLENE GLYCOL, WATER/EAU.

  • Principal Display Panel

    Seequin2__PackageLabel_PrincipalDisplayPanel

    Seequin2__PackageLabel_PrincipalDisplayPanel

  • INGREDIENTS AND APPEARANCE
    SEEQUIN 2 
    hydroquinone liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67226-2620
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE2 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    GRAPEFRUIT (UNII: O82C39RR8C)  
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
    ASCORBIC ACID (UNII: PQ6CK8PD0R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:67226-2620-31 in 1 BOX
    130 mL in 1 BOTTLE, DROPPER
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart358A09/01/2013
    Labeler - Vivier Pharma, Inc. (250996550)
    Establishment
    NameAddressID/FEIBusiness Operations
    Vivier Pharma, Inc.250996550manufacture(67226-2620)